Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers ...
Analyst Mayank Mamtani from B.Riley Financial reiterated a Hold rating on Madrigal Pharmaceuticals (MDGL – Research Report) and keeping the price target at $236.00. Discover outperforming stocks ...
Moreover, Tewari anticipates that Madrigal Pharmaceuticals could surpass FY25 consensus sales estimates under conservative assumptions, bolstered by the company’s strategic position in the NASH ...
Jan 15 | Two popular Portland brands under the ChefStable umbrella are expanding into Beaverton with one set to open later this year. Jan 15 | The shopping center's tenants include Whole Foods ...
Madrigal said that all patients enrolled in MAESTRO-NASH - which include up to 2,000 in total - are continuing on therapy after the initial 52-week treatment period.
The eatery’s giant red-letter sign has been a landmark along Interstate 25, and the restaurant was a staple for those who took Exit 254. “I just heard about it from other people in town ...
Nominations are due for the Houston Business Journal’s annual Landmark Awards by Friday, Jan. 31 — and there are some big changes this year. Nominations are due for the Houston Business ...